ArticleAnnals of medicine and surgery (2012)2025
The neglected epidemic of type 5 diabetes mellitus.
Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Type 5 Diabetes Mellitus: Pathophysiology, Clinical Phenotype, and Nutritional Management.Diabetes/metabolism research and reviews · 2026Review
- Type 5 diabetes mellitus: redefining pancreatogenic diabetes through molecular, imaging, and AI-driven evidence.Frontiers in endocrinology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There are several types of diabetes, but type 1 and type 2 often dominate the discussion. They overshadow lesser-known types like type 5 diabetes (T5DM). T5DM was first identified in 1955 in Jamaica. However, it remained understudied due to limited evidence. Recently, in April 2025, the International Diabetes Federation brought attention to this condition during the World Diabetes Congress. It is estimated to affect 20 to 25 million people, predominantly of Asian and African descent. It disproportionately affects malnourished teens in low- and middle-income countries and is therefore, also known as malnutrition-related diabetes. Despite existing for over 70 years, it remains often misunderstood or misdiagnosed. This may lead to inadequate management of increased risk of complications. This highlights the need for reliable diagnostic criteria and extensive research. Furthermore, we believe addressing type 5 diabetes requires a multifaceted, global approach.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.